Skip to main content
Fig. 4 | BMC Medical Genomics

Fig. 4

From: Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways

Fig. 4

Kaplan–Meier (KM) survival analysis of genomic subgroups versus MDMS8. KM survival analysis showing overall survival (OS) of patients carrying one or more of the following genomic aberrations: [t(4;14), t(14;16), gain1q or del17p] versus the remaining patients (left); overall survival (OS) of patients with genomic aberrations [t(4;14), t(14;16), gain1q or del17p] in MDMS8 versus the same subset of patients in non-MDMS8 subgroups (middle); and progression free survival (PFS) of patients with genomic aberrations [(t(4;14), t(14;16), gain1q or del17p] in MDMS8 versus the same subset of patients in non-MDMS8 subgroups

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us